{"id":748489,"date":"2023-04-18T08:05:04","date_gmt":"2023-04-18T12:05:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/"},"modified":"2023-04-18T08:05:04","modified_gmt":"2023-04-18T12:05:04","slug":"horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/","title":{"rendered":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community<\/b><\/p>\n<p>DUBLIN&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nHorizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the third annual global innovation challenge, The Horizon Prize, powered by MIT Solve.<\/p>\n<p>\nEach year, the Horizon Prize poses a challenge question, asking entrepreneurs and innovators worldwide to think creatively to solve a relevant issue in the rare disease community. One winner will be awarded a total of $150,000 in funding.<\/p>\n<p>\nAn estimated 85% of biomedical research funding is wasted because of inefficiencies, highlighting an opportunity to decrease waste and redundancies while increasing the impact of investments in research and development.<sup>1<\/sup> This year\u2019s question, <b>\u201cHow can we decrease the environmental impact of the rare disease health care space and alleviate burdens for rare disease families?\u201d<\/b> seeks to find a wide variety of technology-based solutions that can address areas including, but not limited to:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nImproving the rare disease patient diagnostic journey (reducing time, cost, etc.)<\/p>\n<\/li>\n<li>\nEnhancing efficiencies in clinical trials and research<\/p>\n<\/li>\n<li>\nReducing single-use products and unnecessary plastics and medical\/hazardous waste throughout research and manufacturing<\/p>\n<\/li>\n<li>\nCreating or promoting alternative packaging that may be reusable, recyclable or biodegradable without compromising sterility or safety<\/p>\n<\/li>\n<li>\nOptimizing the transportation of supplies and treatments by addressing shipping inefficiencies, cold storage and last-mile delivery<\/p>\n<\/li>\n<\/ul>\n<p>\nLearn more and submit an application <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsolve.mit.edu%2Fchallenges%2Fthe-horizon-prize-2023&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=acebe7ff65a29d56d93ec787599df112\">here<\/a> by June 23, 2023.<\/p>\n<p>\n\u201cThis year\u2019s Horizon Prize challenges innovators to bring forward ideas that can decrease research inefficiencies while also addressing issues that rare disease patients and their caregivers face,\u201d said Tim Walbert, chairman, president and chief executive officer, Horizon. \u201cWe have been inspired by previous winners and look forward to the ideas that this year\u2019s participants will bring forward.\u201d<\/p>\n<p>\nThe 2022 Horizon Prize focused on improving quality of life for those diagnosed with rare diseases. The winner, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ebresearch.org%2F&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=EB+Research+Partnership&amp;index=2&amp;md5=1436f0fc29063ba03113991912623c4b\">EB Research Partnership<\/a>, brought a solution that addressed real-time connectivity for patients living with the rare skin disorders Epidermolysis Bullosa (EB) and served as a comprehensive, centralized platform model for the larger rare disease community.<\/p>\n<p>\n\u201cThe funding we received from the Horizon Prize in 2022 provided us with a great foundation to further advance a centralized platform for patients with EB and their caregivers,\u201d said Michael Hund, chief executive officer, EB Research Partnership. \u201cCreating a comprehensive digital platform for patients living with EB has been an important step to improving quality of life and enabling more real-time collaboration between patients, families and the health care providers who can help manage their treatment.\u201d<\/p>\n<p><b>About Horizon<\/b><\/p>\n<p>\nHorizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.horizontherapeutics.com%2F&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=www.horizontherapeutics.com&amp;index=3&amp;md5=a1d1546553f4b0cabbe76a28d1cc3e71\">www.horizontherapeutics.com<\/a> and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FHorizonNews&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=Twitter&amp;index=4&amp;md5=f4eaac7cc79498a9905788813506c391\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fhorizontherapeutics&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=01666dc047e87b4f3b862d27ac063110\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fhorizontherapeutics%2F&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=b03182c70925acf28902ad44c8aad232\">Instagram<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FHorizonTherapeutics%2F&amp;esheet=53382666&amp;newsitemid=20230418005327&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=35a57cc4e94befdd9cd8ecc2864e2658\">Facebook<\/a>.<\/p>\n<p><b>References<\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nUegaki, K., &amp; Billiones, R. (2022). Preventing Biomedical Research Waste. European Medical Writers Association, 31(1), 20\u201325.<\/p>\n<\/li>\n<\/ol>\n<p>\n\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230418005327\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230418005327\/en\/<\/a><\/span><\/p>\n<p>\nMedia:<br \/>\n<br \/>Catherine Riedel<br \/>\n<br \/>Executive Director, Corporate Visibility and Media Strategy<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@horizontherapeutics.com\">media@horizontherapeutics.com<\/a><\/p>\n<p>\nEimear Rigby<br \/>\n<br \/>Associate Director, Corporate Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@horizontherapeutics.com\">media@horizontherapeutics.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York Europe Ireland United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Health University Pharmaceutical Training Education Managed Care General Health Environment Environmental Health Clinical Trials Biotechnology Science Other Science Research Health Medical Supplies<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230418005327\/en\/1460023\/3\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community DUBLIN&#8211;(BUSINESS WIRE)&#8211; Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the third annual global innovation challenge, The Horizon Prize, powered by MIT Solve. Each year, the Horizon Prize poses a challenge question, asking entrepreneurs and innovators worldwide to think creatively to solve a relevant issue in the rare disease community. One winner will be awarded a total of $150,000 in funding. An estimated 85% of biomedical research funding is wasted because of inefficiencies, highlighting an opportunity to decrease waste and redundancies while increasing the impact of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-748489","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community DUBLIN&#8211;(BUSINESS WIRE)&#8211; Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the third annual global innovation challenge, The Horizon Prize, powered by MIT Solve. Each year, the Horizon Prize poses a challenge question, asking entrepreneurs and innovators worldwide to think creatively to solve a relevant issue in the rare disease community. One winner will be awarded a total of $150,000 in funding. An estimated 85% of biomedical research funding is wasted because of inefficiencies, highlighting an opportunity to decrease waste and redundancies while increasing the impact of &hellip; Continue reading &quot;Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-18T12:05:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community\",\"datePublished\":\"2023-04-18T12:05:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/\"},\"wordCount\":631,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/\",\"name\":\"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-04-18T12:05:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/","og_locale":"en_US","og_type":"article","og_title":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk","og_description":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community DUBLIN&#8211;(BUSINESS WIRE)&#8211; Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the third annual global innovation challenge, The Horizon Prize, powered by MIT Solve. Each year, the Horizon Prize poses a challenge question, asking entrepreneurs and innovators worldwide to think creatively to solve a relevant issue in the rare disease community. One winner will be awarded a total of $150,000 in funding. An estimated 85% of biomedical research funding is wasted because of inefficiencies, highlighting an opportunity to decrease waste and redundancies while increasing the impact of &hellip; Continue reading \"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-18T12:05:04+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community","datePublished":"2023-04-18T12:05:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/"},"wordCount":631,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/","name":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-04-18T12:05:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230418005327r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-and-massachusetts-institute-of-technology-mit-solve-announce-the-launch-of-the-third-annual-horizon-prize-to-inspire-sustainable-solutions-for-research-and-care-in-the-rare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/748489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=748489"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/748489\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=748489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=748489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=748489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}